h yperglycemia, a major risk factor for diabetic microvascular complications, induces apoptosis in retinal pericytes, renal podocytes, and vascular endothelial cells (ECs) directly or indirectly through inflammation, oxidative stress, glycated products, or protein kinase C activation. 1, 2 Although intensive glucose control in diabetic patients can delay the onset and progression of diabetic vascular complications, 3, 4 clinicians have frequently failed to effectively prevent the progression of vascular diseases, among them retinopathy, which necessitates further investigation into novel mechanisms of diabetic vasculopathy. 5 Recent advances in vascular biology have revealed that intercellular signaling between adjacent ECs has important roles in the development, remodeling, and homeostasis of vessels. 6 ECs in the capillaries are not static but dynamically changed by intercellular signaling. 7 Notch receptors and their ligands, δ-like ligand 4 (Dll4) and Jagged1, regulate the dynamic and transient intercellular signaling between ECs. Once the Notch extracellular domain of 1 cell interacts with the Dll4 in an adjacent cell, γ-secretase cleaves Notch, thereby releasing the Notch intracellular domain (NICD), which subsequently regulates gene expression via activation of transcription factors. Expression of Dll4 in filopodia-extending ECs (tip cells) leads to the activation of Notch in adjacent ECs and induces stable tube-forming ECs (stalk cells) at the base of sprouts. 8 The vessel-stabilizing activity of the Dll4-Notch interaction is opposed by Jagged1, which destabilizes stalk cells and leads to the immature vessel plexus. 9 Acellular capillaries (eg, empty basement membrane sleeves or ghost vessels) have been reported to be an irreversible result of diabetes-induced EC apoptosis. 2 Acellular capillaries are also observed during developmental angiogenesis in the mouse retina, which is tightly regulated by intercellular signaling via Notch and its ligands. 6 In addition, endothelial glucose metabolism affects developmental angiogenesis by modulating Notch signaling 10 which is crucial for the remodeling of veins and the perivenous capillary plexus after the initial angiogenic growth phase in the postnatal retina. 11 Therefore, it is likely that Notch signaling has a role in adult vascular homeostasis and is affected by dysregulated glucose metabolism.
However, Notch signaling and vascular remodeling in mature adult capillaries have not yet been fully investigated, especially in relation to diabetes mellitus. We demonstrate that abnormal intercellular Notch signaling has a crucial effect on diabetic microvasculopathy (DMV) in the present study.
MethODs Mice
All animal experiments were approved by the Institutional Animal Care and Use Committee of Seoul National University Bundang Hospital. Diabetes mellitus was induced in 8-week-old male C57BL/6 mice by intraperitoneal injection of 150 mg/kg streptozotocin (Sigma Aldrich) dissolved in citrate buffer. Blood glucose levels were measured every week after streptozotocin administration. Induction of diabetes mellitus was defined in mice when their nonfasting blood glucose levels were >250 mg/dL. Hemoglobin A 1c levels were determined with the HITACHI 7070 automatic biochemical analyzer (Hitachi Instruments) at 6 weeks after streptozotocin injection. Eyes, hearts, and thigh muscles were harvested 6 weeks after the induction of diabetes mellitus and compared with a control group. To elucidate the role of Jagged1 in ECs, we used both EC-specific Jagged1 heterozygous deficient (Tie2-Cre+;Jag1 flox/+ ) mice and EC-specific inducible Jagged1 deficient (Tie2-CreER +;Jag1 flox/flox mice received intraperitoneal injection of 1 mg 4-OHT-tamoxifen (OHT; Sigma Aldrich) for 7 consecutive days 4 weeks after the streptozotocin injection.
To confirm that Notch inhibition led to DMV, we generated conditional Mib1 knockout mice under the control of an inducible Tie2 promoter. Tie2-CreER T2 +;Mib1 flox/+ mice received intraperitoneal injection of 1 mg OHT for 7 consecutive days from 8 weeks after birth. We harvested retinas at 10 weeks after birth.
clinical Perspective
What is new?
• Diabetes-induced microvasculopathy (DMV) is characterized by capillary remodeling, regression, or decreased density in the retina, heart, skeletal muscle, and kidneys.
• The upregulation of Jagged1, inhibition of Notch signaling, and abnormal regulation of adhesion molecules in endothelial cells are the underlying mechanisms of DMV.
• Using 2 types of transgenic mice, which enabled endothelium-specific and/or time-specific Notch signaling modulation, we were able to reverse abnormal capillarity under diabetic conditions by downregulating Jagged1.
• Taking these results together, we identified a pathological intercellular signaling as a novel mechanism of DMV.
What are the clinical implications?
• Capillary remodeling and rarefaction should be considered in the pathogenesis, diagnosis, and treatment of DMV, including diabetic retinopathy, diabetic cardiomyopathy, and diabetic nephropathy.
• Dysregulated intercellular Notch signaling and upregulated Jagged1 could be novel molecular targets for the treatment of DMV beyond glucose control.
• Because microvasculature in adults maintains its homeostasis under the control of endothelial intercellular signaling, microvasculature and intercellular signaling should be investigated in other pathological conditions.
immunofluorescence Quantification of retinal Vasculopathy
Images were generated for comparative analysis under identical conditions of light, contrast, and magnification. Capillary density, diameter, and mean fluorescence intensity were measured by ImageJ software (National Institutes of Health). This program automatically detects signal pixel area. If the staining is very specific, that is, if the signal-to-noise ratio is high, the capillary area tends to be low. If the staining is not specific, the capillary area becomes high because noise is included in the area. We performed BS-1 lectin staining for each set of experiments at the same time. However, it is hard to compare the results between the different sets of experiment in the present study because of staining variation. We directly evaluated the capillary diameter at various points of interest in z-stack images by measuring the width of the lectin-positive area perpendicular to the capillary length using ImageJ software. Therefore, the capillary diameter in our data denotes the abluminal diameter of the capillary, not luminal diameter. We counted a capillary as acellular if the diameter of the lectin-stained structure was markedly different from the adjacent capillaries and did not contain a nucleus.
apoptosis and Proliferation analysis
The Methods section in the online-only Data Supplement provides a description of apoptosis and proliferation analysis.
genotyping and reverse transcriptionPolymerase chain reaction
The Methods section in the online-only Data Supplement provides a description of genotyping and reverse transcriptionpolymerase chain reaction. 
statistical analysis
Statistical analyses were performed with GraphPad Prism 5 (GraphPad Software). Differences in continuous variables between experimental groups were analyzed by the Student t test or 1-way ANOVA followed by Tukey post hoc analysis. All results are expressed as mean±SEM.
resUlts
We induced diabetes mellitus in mice by intraperitoneal administration of 150 mg/kg streptozotocin. Blood glucose levels were maintained at >400 mg/dL, and the hemoglobin A 1c level was 7.2% at 6 weeks ( Figure I in the online-only Data Supplement). At this point, we identified DMV. In the diabetic mice, capillary area and capillary diameter were significantly decreased ( Figure 1A and 1B). These changes were more prominent in the peripheral retinal region than in the central region near the optic disc. Therefore, we performed further analysis in the peripheral retinal region. We separately analyzed the 3 layers of the retinal capillaries -superficial, intermediate, and deep -according to their proximity to the vitreous body ( Figure 1C ). Compared with normal mice, diabetic mice showed a marked decrease in capillary density (percent capillary area/retinal area; Figure 1D and 1E). Acellular capillaries were markedly increased in diabetic mice, especially in the deep layer ( Figure 1F ). In addition, the diameter of the intact capillaries with lumens was narrower in diabetic mice than in normal controls ( Figure 1G ). We also confirmed DMV in the 3-dimensional retinal vascular structure from diabetic mice (Video I in the online-only Data Supplement), which was not found in control mice (Video II in the online-only Data Supplement). We evaluated retinal cell death using various methods, including terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, cleaved caspase-3 staining of the retina, and flow cytometry of cells isolated from the retina with Annexin V and propidium iodide. Endothelial apoptosis was too rare to explain the marked microvascular differences ( Figure IIa We observed a dynamic capillary growth or regression in an in vitro model of human angiogenesis (Video III in the online-only Data Supplement). Similarly, we observed 2 different acellular capillaries in vivo: regressing vessels, having thick type IV collagen deposition, and growing vessels having thin or no type IV collagen lining ( Figure 1H ). Therefore, we surmised that diabetes mellitus increased dynamic capillary remodeling and regression, leading to decreased capillary density in adult mice. We also found that the number of acellular capillaries in the heart was significantly increased in the diabetic mice ( Figure 1I and 1J) . The capillary diameter in the heart of diabetic mice was also markedly decreased ( Figure 1K and 1L). The regressing vessels having thick type IV collagen deposition without lectin staining were significantly increased in the diabetic heart ( Figure 1M and 1N) . In contrast, the growing vessel, having thin or no type IV collagen lining, was not different in both groups ( Figure  1O and 1P) .
We hypothesized the existence of a novel mechanism of DMV in which a disturbance of the endothelial Notch signaling pathway may cause cell-to-cell miscommunication, leading to capillary regression. Two Notch ligands (Dll4 and Jagged1) are expressed in the vasculature.
12 Jagged1 was highly expressed in the diabetic retinal capillaries compared with those in controls ( Figure 2A ). Jagged1 signal intensity in ECs markedly increased in the diabetic mice ( Figure 2B ). Jagged1 in the capillaries of diabetic heart, skeletal muscle, and glomerulus of the kidney was also upregulated ( A, Whole-mounted retinas with lectin staining of streptozotocin (STZ)-induced diabetic C57BL/6 mice showed a reduction of capillary density and diameter in both central and peripheral regions compared with normoglycemic retinal controls (CTL). B, Quantification of retinal capillary density and diameter in control and STZ mice (n=6 for each group). Capillary density is expressed as the percentage of the BS-1 lectin-stained area, and capillary diameters were evaluated by measuring the width of the lectin-positive area perpendicular to the capillary length with ImageJ software. C, A cross section displayed 3 vascular layers of the adult retina, superficial, intermediate, and deep, according to the proximity from the vitreous fluid. Yellow dashed lines delineate the borders of the retinal layers. D, Whole-mounted retinas of STZ mice displayed a reduction in capillary density and an increase in acellular capillaries across all 3 retinal layers compared with control mice. E through G, Quantification of retinal capillaries in control and STZ mice. STZ mice showed reduced density of retinal capillaries in all 3 retinal capillary layers (n=7 for each group). A marked increase in the number of acellular capillaries was observed in the deep retinal layers of the STZ mice (n=7 for each group). Additionally, a decrease in capillary diameter was observed in STZ mice (n=9 for each group). H, Immunofluorescence staining for type IV collagen (red), BS-1 lectin (white), and DAPI (blue) of whole-mounted mouse retinas. Two different types of acellular capillaries were present, according to the patterns of type IV collagen: one with thick type IV collagen deposition (presumably a regressing vessel) and another with thin or no type IV collagen lining (possibly a growing or sprouting vessel). I through N, Analysis of capillaries in the heart of control and STZ mice. I through J, BS-1 lectin staining in the heart capillaries of control and STZ mice (I) and quantification of acellular capillary numbers per image field (J; n=3). Arrows indicate acellular capillaries in the STZ mouse. K and L, BS-1 lectin staining in the heart capillaries of control and STZ mice (K) and quantification of capillary diameter (L; n=3). M-P, Immunofluorescence staining for type IV collagen (red) and BS-1 lectin (green) in heart capillaries of control and STZ mice (M) and a graph showing the percentage of collagen V + /lectin − vessels (arrowheads, N; n=3 for control, n=4 for STZ).
endothelial Jagged1 overexpression is the primary mechanism for DMV, we assessed the effect of diabetes mellitus in endothelium-specific Jagged1 knockdown mice, Tie2-Cre+;Jagged1 flox/+ . We confirmed the endotheliumspecific knockdown of Jagged1 in isolated ECs from these mice ( Figure 3A ). In the normoglycemic condition, Tie2-Cre+;Jagged1 flox/+ mice did not display any capillary abnormality compared with Tie2-Cre+;Jagged1
wild-type mice ( Figure 3B and 3C) . Diabetic wild-type mice (Tie2-Cre+;Jagged1 +/+ ) developed apparent DMV. However, knockdown of Jagged1 in ECs as in Tie2-Cre+;Jagged1 flox/+ mice markedly attenuated DMV even under diabetic conditions ( Figure 3B and 3C) .
Furthermore, to confirm that the established DMV was reversed by modulation of Jagged1, that is, to determine whether DMV could be treated and cured, we suppressed Jagged1 expression in ECs at 4 weeks after diabetes induction using an inducible knockdown model, Tie2-CreERT2+;Jagged1 flox/flox mice. We confirmed that DMV was established at 4 weeks after diabetes induction ( Figure 4A and 4B). Starting from 4 weeks after diabetes induction, we administered OHT or vehicle for 7 days ( Figure 4C ). Endothelium-specific inducible knockdown of Jagged1 was confirmed in isolated ECs from the mice ( Figure 4D ). We evaluated the efficiency of Tie2-Cre-ERT2-mediated recombination using Rosa26-eYFP mice ( Figure flox/flox mice (streptozotocin group) showed vivid DMV in the retina compared with control ( Figure 4E and 4F), knockdown of Jagged1 at 4 weeks after diabetes induction by treatment with OHT (OHT group) markedly reversed the established DMV during the next 4 weeks compared with the streptozotocin group. Immunofluorescent staining of Jagged1 confirmed its downregulation in the streptozotocin+OHT group compared with the streptozotocin+vehicle group ( Figure 5A and 5B). This result supports the observation that downregulation of Jagged1 can rescue capillary regression and vascular remodeling under high-glucose conditions. A, Immunofluorescence staining of Jagged1 (white), BS-1 lectin (red), and DAPI (blue) in adult whole-mounted mouse retinas. In control mice, Jagged1 expression is observed in most of the retinal cells but not ECs of capillary. When we focus on ECs of retinal capillary, endothelial expression of Jagged1 is stronger in diabetic mice than in normoglycemic mice. B, Quantification of endothelial Jagged1 immunostaining fluorescence intensity in the retinal capillaries of the 3 layers (n=6 for each group). Jagged1 was markedly overexpressed in the retinal capillaries of diabetic mice. C, Immunofluorescence staining of Jagged1 (red), and BS-1 lectin (green) in the myocardial capillaries of control and streptozotocin (STZ) mice showing increased Jagged1 expression in the capillaries of diabetic mice. Jagged1 expression is negligible in the background myocytes, which is different from retinal cells. Arrows indicate Jagged1 staining. D, Quantification of endothelial Jagged1 staining fluorescence intensity in the heart capillaries (n=3).
To examine the downstream of Jagged1 induction by diabetes mellitus, we assessed the signal activity of Notch1 using immunofluorescent staining of full-length Notch1 and NICD1. ). Representative images of the deep layer of the retinas showed that diabetes caused vasculopathy, which was prevented by knockdown of endothelial Jagged1 in diabetic mice. C, Quantification of the deep capillary layers: capillary density (n=7 for each group), number of acellular capillaries (n=7 for each group), and capillary diameter (n=9 for each group). CTL indicates control; and STZ, streptozotocin.
of Notch1 and NICD1 expression, we cropped the Notch1 or NICD1 signal within ECs or endothelial nuclei. Next, we quantified the signal intensity of Notch1 or NICD1 ( Figure XII in the online-only Data Supplement).
Endothelial Notch1 expression was not substantially different between normoglycemia and diabetes mellitus in the retina and heart ( Figure 6A-6C) . In contrast, NICD1 signal intensity was markedly lower in the diabetic ECs of retina, heart, and skeletal muscle than in normoglycemic ECs, which suggests that diabetes mellitus inhibits Notch1 signaling in ECs ( Figure 6D -6F and Figure XIII in the online-only Data Supplement). A downstream molecule of NICD1, HEY1, was also significantly decreased in the diabetic myocardial ECs (Figure 6G and 6H) . Endothelium-specific knockdown of Jagged1 did not affect Notch1 expression in the diabetic mice ( Figure 6I and 6K). In contrast, it significantly recovered NICD1 (Figure 6J and 6L ). This suggests that the decrease in NICD1 is mediated by Jagged1 upregulation in the diabetic condition and that NICD1 can be restored by inhibiting Jagged1 upregulation. Similarly, endothelium-specific inducible knockdown of Jagged1 at 4 weeks after diabetes induction did not change Notch1 expression, whereas it significantly increased NICD1, suggesting that the decrease of NICD1 was reversed by Jagged1 knockdown in the diabetic condition ( Figure 6M and 6N) .
To confirm whether Notch inhibition induces retinal capillary regression in adults, we introduced the chemical Notch inhibitor DAPT via intraperitoneal injection. Chemical Notch inhibition phenocopied the capillary changes in diabetic mice and induced microvasculopathy in normal mice ( Figure 7A and 7B) . Another chemical Notch inhibition with dibenzazepine also showed changes similar to the DMV and DAPT inhibition ( Figure 7C and 7D) . We confirmed the downregulation of NICD1 and HEY1 in endothelial cells in both chemical inhibition experiments, whereas full-length Notch1 expression was not affected ( 
+;Jag1
flox/flox mice. EC-specific knockdown of Jagged1 recovered capillary density and corrected retinal vasculopathy in diabetic mice. F, Quantification of the deep retinal capillary layers: capillary density (n=5 for each group), acellular capillaries (n=12 for each group), and capillary diameter (n=9 for each group). Three characteristics of microvasculopathy were recovered by EC-specific knockdown of Jagged1.
Next, we investigated whether the endothelial junction is affected by Notch inhibition to demonstrate a possible mechanism of DMV. In in vitro culture, endothelial tubes showed well-organized cell-to-cell junctions by VE-cadherin in the presence of intact Notch signaling ( Figure 8C ). However, VE-cadherin was downregulated by inhibition of Notch signaling with shRNA against Mib-1 ( Figure 8D ). Likewise, C57BL/6 control mice showed higher expression of VE-cadherin and N-cadherin in the retinal endothelial cells than diabetic C57BL/6 mice (Figure 8E and 8G and Figure XVa and XVb in the online-only Data Supplement). We also investigated whether Notch inhibition affected VE-cadherin and N-cadherin using Tie2CreERT2+;Mib1 f/+ transgenic mice. Endotheliumspecific inducible Mib1 knockdown significantly reduced those adhesion molecules compared with control mice ( Figure 8F and 8H and Figure XVc and XVd in the onlineonly Data Supplement). These downregulations of VEcadherin in diabetic condition increased the number of disconnected linings of VE-cadherin and ZO1 stainings, which indicate a single tubular endothelial cell in unstable capillaries ( Figure 8I , 8J, 8L, and 8M). Diabetes mellitus also increased aggregated VE-cadherin, which indicated collapsed and regressed vessels ( Figure 8I and 8K ).
DiscUssiOn
We show that diabetes mellitus induces DMV, characterized by capillary remodeling, regression, or decreased density, in adult mice. Notch ligand Jagged1, but not Dll4, was markedly increased in the ECs of diabetic mice. When Jagged1 expression was attenuated, as in endothelium-specific-Jagged1 knockdown mice, DMV was effectively prevented, even under diabetic conditions. Furthermore, when endothelial Jagged1 expression was suppressed 4 weeks after the diabetes induction in inducible endothelial Jagged1 knockdown mice, DMV was reversed and the retinal vasculature was normalized, suggesting therapeutic potential at this target. Diabetes mellitus and Jagged1 overexpression decreased the nuclear localization of NICD1 in ECs. Chemical Notch inhibition phenocopied DMV in normal mice. Diabetes mellitus and Notch inhibition decreased endothelial junctional molecules, which led to capillary regression. Taken together, these results indicate that short-term exposure to diabetes mellitus induced endothelial Jagged1 expression, which mediates reversible DMV via Notch1 signaling inhibition in adult mice ( Figure XVI in the online-only Data Supplement).
intercellular signaling as a novel Mechanism of DMV
ECs and pericytes are implicated in the progression to classic diabetic microvascular disease. Molecular mechanisms included the induction of the aldose reductase pathway, protein kinase C, oxidative stress, protein glycation, or hexosamine pathway. 13 These intracellular changes are suggested to cause apoptosis of endothelial cells and pericytes and leukocyte trafficking, resulting in microvasculopathy. 14 However, we did not find a significant increase in endothelial apoptosis in the diabetic retina by all apoptosis detection methods, including terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, cleaved caspase 3 staining, propidium iodide, and annexin V, although there was DMV in the present study. These facts warrant investigation of another mechanism for early microvasculopathy.
Recently, intercellular signaling between adjacent ECs has been reported to play important roles in the development, remodeling, and homeostasis of vessels. 6 Delicate regulation and balance between tip cells and stalk cells via cell-to-cell signaling are needed in vascular biology. Therefore, we investigated the role of intercellular signaling in adult capillaries under the diabetic condition. Because ECs in the capillaries dynamically change by intercellular signaling, 7 we predicted that we would be able to observe changes in intercellular signaling in the capillaries after exposure to diabetes mellitus. As a result, we could identify the disturbed Jagged1/Notch signaling in capillaries of our diabetic mouse model.
Disturbed Jagged1 and notch signaling in a Murine Diabetic Model
Notch signaling is closely related to the formation and maintenance of the vascular system. 8, 9, 15 Notch1 and its ligands, Dll4 and Jagged1, are well-known molecules involved in intercellular signaling in the vessels.
The most prominent change in the ECs of diabetic mice was the induction of Jagged1 in the present study. It is interesting that Dll4, another ligand for Notch, did not change in the diabetic condition, suggesting the specific response of Jagged1 to diabetes mellitus. We previously reported the in vitro observation that hyperglycemia increased endothelial expression of Jagged1 through nuclear factor-κB and protein kinase C, 16 which was corroborated by other reports that protein kinase C induces nuclear factor-κB, 2 the upstream regulator of Jagged1. 17 We tested the causal relationship between Jagged1 induction and DMV using 2 different genetically engineered mouse models: mice with endothelium-specific knockdown of Jagged1 and mice with endotheliumspecific inducible knockdown of Jagged1. In the first model, we confirmed that blocking Jagged1 could prevent the development of DMV even in the diabetic condition. In the second model, we observed the valuable result that modulation of Jagged1 may be a therapeutic strategy for established DMV in the diabetic condition. Induction of Jagged1 knockdown in ECs at 4 weeks after diabetes mellitus or the establishment of DMV could reverse DMV, resulting in the normalization of retinal vasculature in diabetes mellitus. Because not only the retina but also the heart, limb muscle, kidney, and in vitro human endothelial cells showed Jagged1 overexpression in response to diabetes mellitus, Jagged1 overexpression seems to be a generalized endothelial response to diabetes mellitus.
As a downstream mechanism after induction of Jagged1 in diabetic ECs, we evaluated the Notch signaling by assessing total Notch1 and NICD1. Endothelial Notch signaling is crucial for the remodeling of veins and the perivenous capillary plexus in the postnatal retina. 11 In the present study, we found that nuclear localization of NICD1 was suppressed in the retinal ECs of diabetic mice, whereas total Notch1 was not affected. Jagged1 can inhibit Notch signaling as a cell autonomous process, known as cis-inhibition. 18 In the signal-receiving cells, the overexpressed Jagged1 may bind and inhibit Notch in the same cells (cis-inhibition), which inhibits transactivation from the signal-sending cells (such as Dll4 on adjacent cells). The balance between Dll4 and Jagged1 is important in regulating Notch signaling and vascular growth. 19 In the present study, we found that diabetes mellitus induced an imbalance between Jagged1 and Dll4, favoring Jagged1 and resulting in the suppression of nuclear localization of NICD1 Notch activity. Our findings that chemical and genetic Notch inhibition phenocopied DMV demonstrate the importance of Notch suppression in the pathobiology of DMV under diabetic conditions. We previously reported a high glucose-induced abnormal angiogenesis in an in vitro model using human endothelial cells, which included increased numbers of regressing tubes and decreased vascular diameter, length, area, and growing tubes. 16 We Figure 6 continued. wild-type mice showed no difference between the normoglycemic and diabetic mice (n=7 for each group of retina, n=3 for each group of heart). D, Immunofluorescence staining for Notch intracellular domain 1 (NICD1; red) in the nucleus (blue) of myocardial capillaries. E and F, NICD1 immunostaining fluorescence intensity in retinal and heart endothelial nuclei markedly decreased in the diabetic mice compared with the normoglycemic control mice (n=5 for each group's retina, n=3 for each group's heart). G, Immunofluorescence staining for HEY1 (red) in the nucleus (blue) of myocardial capillaries. H, Quantification of HEY1 staining fluorescence intensity within endothelial nucleus demonstrating the decreased HEY1 expression in the nucleus of the STZ mice compared with control mice (n=3). I through L, Analysis of myocardial capillary showing that endothelium-specific knockdown of Jagged1 recovered nuclear localization of NICD1, which was decreased by STZ. I and J, Endotheliumspecific knockdown of Jagged1 using Tie2-Cre+;Jag1 flox/+ mice and control experiments using Tie2-Cre+;Jag1 +/+ mice. BS-1 lectin (green) and DAPI (blue). suggest that Jagged1 overexpression and inhibition of Notch1 signaling are the underlying mechanism of the abnormalities. The disturbed Jagged1/Notch signaling may be the key mechanism of DMV.
Interestingly, endothelial glucose metabolism is reported to affect Notch signaling and developmental angiogenesis. 10 De Bock and colleagues 10 have shown that increased endothelial glucose metabolism by overexpression of phosphofructokinase-2/fructose-2,6-bisphosphatase, a glycolytic enzyme in ECs, masked the vascular stabilizing activity of Notch, whereas decreased glycolysis in ECs impaired tip cell formation on Notch blockade, implying that glycolysis in endothelial cells regulates vessel branching. Intriguingly, Notch signaling disturbance in the upregulated glycolysis was similar to that in the diabetic condition in our study. In that condition, ECs take up a high level of glucose into their cytoplasm, which may mimic the condition with overexpressed glycolytic enzyme. The most interesting finding in the present study is that capillary rarefaction after notch inhibition in adult mice occurs in contrast to the hypersprouting and increased angiogenesis in postnatal angiogenesis. We observed a number of different occurrences in the adult retina. First, the expression of vascular endothelial growth factor receptors 2 and 3 in the adult retina was weak compared with that in the postnatal retina and was not changed after diabetes mellitus ( Figure XVII in the online-only Data Supplement). Vascular endothelial growth factor receptor downregulation during vascular maturation was reported in a previous study. 11 Second, endothelial proliferation is very rare and not increased in the adult retina, as demonstrated in Figure III in the online-only Data Supplement. This is also consistent with the previous report.
11
Vascular endothelial growth factor signaling and endothelial proliferation are necessary for postnatal sprouting angiogenesis. The lack of angiogenic signaling might be the reason why Notch inhibition does not induce sprouting angiogenesis in the adult retina.
Third, endothelial junctional Notch is known to regulate the transcription of N-cadherin through association with the Notch intracellular complex at the RBP-J binding site of the N-cadherin promoter. 20 Notch activity is also quantitatively related to VE-cadherin turnover and mobility at endothelial cell junctions during angiogenic sprouting. 21 We found that VE-cadherin and N-cadherin were significantly reduced in the diabetic mice and the mice with lower notch activity. These findings reveal that a decrease in endothelial Notch signaling in the adult results 
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flox/+ mice). I through M, Analysis of myocardial capillary in control and STZ mice. I, Confocal images of capillaries in the hearts of diabetic mice. Yellow arrows indicate the disconnected VE-cadherin in an intact endothelial tube. White arrows indicate the collapsing capillaries that showed aggregated VE-cadherin staining and a narrow endothelial tube. BS-1 lectin (green), VE-cadherin (red), and nuclei (blue). Scale bar=20 μm. J, Quantification of myocardial capillaries containing disconnected VE-cadherin staining in control and diabetic mice (percent of total capillaries; n=3). K, Quantification of myocardial collapsing capillaries (percent of total capillaries; n=3). L, Confocal images of myocardial capillaries of diabetic mice. Disconnected ZO1 in an intact endothelial tube or in a narrowed endothelial tube is denoted between arrows. BS-1 lectin (green), ZO1 (red), and nuclei (blue). Scale bar=10 μm. M, Quantification of myocardial capillaries containing disconnected ZO1 staining (percent of total capillaries; n=3). CTL indicates control; and GFP, green fluorescent protein.
in microvascular abnormalities without angiogenesis. Fourth, in contrast to the many ECs found within postnatal capillaries, matured capillaries in the retina contained tubules formed by single, hollowed ECs, single ECs with autocellular junctions, or 2 ECs with 2 adherens junctions. 11 We found that diabetes mellitus or Notch inhibition increased single, hollowed ECs and an autocellular junction with loss of lumens. The different capillary composition may also be related to capillary rarefaction after Notch inhibition in the adult.
a novel target to control DMV Other than glucose control
It is well known that DMV can be prevented by intensive glucose control. 22, 23 However, this is almost always associated with serious complications such as hypoglycemia. 24 Until now, therapeutic trials by targeting the previously proposed pathophysiology of diabetic vasculopathy have failed to prove clinical efficacy because, in part, the mechanism of diabetic vasculopathy is too complex and heterogeneous for one to decide on a target. 1 However, intercellular signaling has not been tested as a target.
We found that the capillary was a dynamic structure undergoing sprouting and regression, which are regulated by Notch signaling. Thus, we surmise that capillary integrity and Notch signaling should be further evaluated in various vascular diseases, including hypertension, diabetes mellitus, and microvascular angina. Specifically, we revealed, for the first time, that Notch signaling in adult mice was affected by diabetes mellitus, a potentially novel mechanism of DMV at an early phase. Until now, the only treatment to prevent DMV has been intensive glucose control, which may cause fatal hypoglycemia. 24 Therefore, novel molecular targets are required. In this context, Jagged1 or Notch signaling in ECs may be feasible therapeutic targets for DMV. In this study, a chemical inhibitor of Notch signaling easily phenocopied DMV, suggesting the possibility of a chemical agonist of Notch signaling as a new option to prevent DMV. Furthermore, using endothelium-specific inducible knockdown mice, we showed that downregulation of Jagged1 after the establishment of DMV could reverse DMV and normalize the retinal vasculature even in a diabetic condition. This finding may be the basis for the development of new therapeutic strategies to treat DMV.
limitations
It is not possible to assess all forms of cell death in vivo. Particularly, necrosis, necroptosis, and late apoptosis cannot be distinguished by single observation with conventional staining methods. Therefore, we could not rule out other enhanced forms of cell death in the diabetic mice.
There may be some differences in the level of Jagged1 expression in the retinal cells compared with endothelial cells. Because the Jagged1 expression in retinal epithelial cells is beyond the scope of this study, we did not perform further experiments to assess the generalizability of results from endothelial cell to retinal epithelial cells. However, we do not think that any potential difference in Jagged1 expression in the retinal cells compared with endothelial cells diminishes the importance of endothelial Notch signaling in the mechanism of DMV because endothelium-specific modulation of Jagged1 did change capillaries in the diabetic mice.
Taken together, our results show that diabetes mellitus induces Jagged1 overexpression and suppresses Notch signaling in ECs, leading to DMV in adult mice. We conclude that dysregulated intercellular Notch signaling may be a novel mechanism explaining DMV.
